This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a significant role in the development of drugs targeting central nervous system disorders, including antidepressants and anxiolytics. Its structural properties allow it to interact with specific neurotransmitter receptors, making it valuable for designing compounds with therapeutic effects. Additionally, it is employed in research settings to study the pharmacological activity of fluorinated organic molecules, aiding in the discovery of new drug candidates.